CDT EQUITY INC. Comprehensive Income
CDT EQUITY INC. (CDT) reported Comprehensive Income of -$4.71 million for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-09-08
- CDT EQUITY INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$4.71M.
- CDT EQUITY INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$3.82M.
- CDT EQUITY INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$21.56M.
- CDT EQUITY INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$7.17M.
- CDT EQUITY INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$799.00K.
- CDT EQUITY INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$4.13M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.71M S-1 · filed 2026-09-08 | -$8.53M S-1 · filed 2026-09-08 | -$30.09M derived: sum of 3 quarters · filed 2026-09-08 | -$37.26M derived: sum of 4 quarters · filed 2026-09-08 | |||
| 2026-03-31 | -$3.82M 10-Q · filed 2026-07-15 | -$25.37M derived: sum of 2 quarters · filed 2026-09-08 | -$32.54M derived: sum of 3 quarters · filed 2026-09-08 | -$38.65M derived: sum of 4 quarters · filed 2026-09-08 | |||
| 2025-12-31 | -$21.56M derived: S-1 12 month − 10-Q 9 month · filed 2026-09-08 | -$28.73M derived: sum of 2 quarters · filed 2026-09-08 | -$34.83M derived: sum of 3 quarters · filed 2026-09-08 | -$39.65M S-1 · filed 2026-09-08 | |||
| 2025-09-30 | -$7.17M 10-Q · filed 2025-11-13 | -$13.28M derived: sum of 2 quarters · filed 2026-09-08 | -$18.10M 10-Q · filed 2025-11-13 | -$20.36M derived: sum of 4 quarters · filed 2026-09-08 | |||
| 2025-06-30 | -$6.11M S-1 · filed 2026-09-08 | -$10.93M S-1 · filed 2026-09-08 | -$13.19M derived: sum of 3 quarters · filed 2026-09-08 | -$19.77M derived: sum of 4 quarters · filed 2026-09-08 | |||
| 2025-03-31 | -$4.82M 10-Q · filed 2026-07-15 | -$5.21M 10-Q · filed 2025-05-15 | -$7.08M derived: sum of 2 quarters · filed 2026-09-08 | -$13.66M derived: sum of 3 quarters · filed 2026-09-08 | -$19.05M derived: sum of 4 quarters · filed 2026-09-08 | ||
| 2024-12-31 | -$2.26M derived: S-1 12 month − 10-Q 9 month · filed 2026-09-08 | -$8.84M derived: sum of 2 quarters · filed 2026-09-08 | -$14.22M derived: sum of 3 quarters · filed 2026-09-08 | -$17.80M S-1 · filed 2026-09-08 | |||
| 2024-09-30 | -$6.58M 10-Q · filed 2025-11-13 | -$11.96M derived: sum of 2 quarters · filed 2025-11-13 | -$15.54M 10-Q · filed 2025-11-13 | -$15.59M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$5.38M 10-Q · filed 2025-08-14 | -$8.96M 10-Q · filed 2025-08-14 | -$9.01M derived: sum of 3 quarters · filed 2025-08-14 | -$5.78M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$3.58M 10-Q/A · filed 2025-08-14 | -$3.63M derived: sum of 2 quarters · filed 2025-08-14 | -$395.00K derived: sum of 3 quarters · filed 2025-08-14 | -$2.51M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2023-12-31 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $3.18M derived: sum of 2 quarters · filed 2025-03-28 | $1.06M derived: sum of 3 quarters · filed 2025-03-28 | -$799.00K 10-K · filed 2025-03-28 | |||
| 2023-09-30 | $3.23M 10-Q · filed 2024-11-14 | $2.60M 10-Q · filed 2023-11-20 | $1.12M derived: sum of 2 quarters · filed 2024-11-14 | -$744.00K 10-Q · filed 2024-11-14 | -$2.28M 10-Q · filed 2023-11-20 | -$4.40M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$2.12M 10-Q/A · filed 2024-11-14 | -$2.49M 10-K · filed 2024-04-16 | -$4.05M 10-Q/A · filed 2024-11-14 | -$4.42M 10-K · filed 2024-04-16 | -$7.64M derived: sum of 3 quarters · filed 2024-11-14 | -$7.99M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-03-31 | -$1.94M 10-Q/A · filed 2024-11-14 | -$5.52M derived: sum of 2 quarters · filed 2024-11-14 | -$5.87M derived: sum of 3 quarters · filed 2024-11-14 | ||||
| 2022-12-31 | -$3.59M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | -$3.94M derived: sum of 2 quarters · filed 2024-04-16 | -$4.13M 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | -$348.00K 10-Q/A · filed 2023-11-21 | -$547.00K 10-Q/A · filed 2023-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |